Disorder-specific brain volumetric abnormalities in Attention-Deficit/Hyperactivity Disorder relative to Autism Spectrum Disorder.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2020
2020
Historique:
received:
06
07
2020
accepted:
22
10
2020
entrez:
9
11
2020
pubmed:
10
11
2020
medline:
9
1
2021
Statut:
epublish
Résumé
The overlap/distinctiveness between Attention-Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD) has been increasingly investigated in recent years, particularly since the DSM-5 allows the dual diagnosis of ASD and ADHD, but the underlying brain mechanisms remain unclear. Although both disorders are associated with brain volumetric abnormalities, it is necessary to unfold the shared and specific volume abnormalities that could contribute to explain the similarities and differences in the clinical and neurocognitive profiles between ADHD and ASD. In this voxel-based morphometry (VBM) study, regional grey matter volumes (GMV) were compared between 22 children with ADHD, 18 children with ASD and 17 typically developing (TD) children aged 8 to 12 years old, controlling for age and total intracranial volume. When compared to TD children or children with ASD, children with ADHD had a larger left precuneus, and a smaller right thalamus, suggesting that these brain abnormalities are specific to ADHD relative to ASD. Overall, this study contributes to the delineation of disorder-specific structural abnormalities in ADHD and ASD.
Identifiants
pubmed: 33166335
doi: 10.1371/journal.pone.0241856
pii: PONE-D-20-20844
pmc: PMC7652272
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0241856Déclaration de conflit d'intérêts
Isabelle Massat received an investigator-initiated research grant from Shire Pharmaceutical Development Limited, a member of the Takeda group of companies (Study ID: IST-BEL- 00520). This does not alter our adherence to PLOS ONE policies on sharing data and materials. Ariadna Albajara Sáenz is supported by a grant from the Belgian Kids’ Fund (www.belgiankidsfund.be), the David et Alice Van Buuren Fund and by the Fondation Jaumotte-Demoulin. Isabelle Massat and Ariadna Albajara Sáenz are supported by the Fonds National de la Recherche Scientifique (FNRS)-Belgium and the Fonds Erasme. The funders had no role in the study design, the data collection and analysis, the decision to publish, or the preparation of the manuscript.
Références
J Abnorm Child Psychol. 2013 Aug;41(6):959-69
pubmed: 23605958
Am J Psychiatry. 2011 Nov;168(11):1154-63
pubmed: 21865529
J Autism Dev Disord. 2000 Jun;30(3):205-23
pubmed: 11055457
Lancet Psychiatry. 2017 Apr;4(4):310-319
pubmed: 28219628
JAMA Psychiatry. 2016 Aug 1;73(8):815-825
pubmed: 27276220
Autism Res. 2012 Feb;5(1):49-66
pubmed: 22139976
Biol Psychiatry. 2018 Apr 1;83(7):579-588
pubmed: 29146048
Neuropsychopharmacology. 2017 Jan;42(2):572-580
pubmed: 27681441
Eur J Neurosci. 2010 Mar;31(5):912-9
pubmed: 20374289
J Autism Dev Disord. 1994 Oct;24(5):659-85
pubmed: 7814313
Neurosci Biobehav Rev. 2015 Jul;54:29-37
pubmed: 25862940
J Am Acad Child Adolesc Psychiatry. 1997 Jul;36(7):980-8
pubmed: 9204677
PLoS One. 2016 Nov 2;11(11):e0165620
pubmed: 27806078
Appl Neuropsychol Child. 2015;4(2):89-96
pubmed: 25748775
Front Psychiatry. 2018 Oct 23;9:521
pubmed: 30405459
Neuroimage Clin. 2014 Nov 18;7:525-36
pubmed: 25844306
J Neurosci. 2017 Jun 7;37(23):5594-5607
pubmed: 28450543
Neuroimage. 2009 Jan 1;44(1):83-98
pubmed: 18501637
Ment Retard Dev Disabil Res Rev. 2004;10(2):106-11
pubmed: 15362165
Biol Psychiatry. 2007 Jun 15;61(12):1361-9
pubmed: 16950217
BMC Psychiatry. 2008 Jun 30;8:51
pubmed: 18590567
Psychol Med. 2015 Apr;45(5):965-76
pubmed: 25229248
Neuroimage. 2008 Jul 1;41(3):903-13
pubmed: 18424084
J Child Psychol Psychiatry. 2007 Dec;48(12):1251-8
pubmed: 18093031
J Autism Dev Disord. 1980 Mar;10(1):91-103
pubmed: 6927682
Acta Psychiatr Scand. 2012 Feb;125(2):114-26
pubmed: 22118249
J Neurol Neurosurg Psychiatry. 2011 Dec;82(12):1304-13
pubmed: 21693631
Neurosci Biobehav Rev. 2012 Nov;36(10):2248-56
pubmed: 22922163
Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19649-54
pubmed: 18024590
Autism Res. 2016 Jan;9(1):67-81
pubmed: 25962921
Neuroimage. 2012 Feb 15;59(4):3548-62
pubmed: 22116037
Dev Med Child Neurol. 2019 Apr;61(4):399-405
pubmed: 30276811
Brain Imaging Behav. 2017 Apr;11(2):541-551
pubmed: 26941174
J Autism Dev Disord. 2013 Jul;43(7):1630-41
pubmed: 23138728
Brain Res. 2011 Mar 22;1380:138-45
pubmed: 20920490
Br J Clin Psychol. 2010 Jun;49(Pt 2):235-58
pubmed: 19646334
J Autism Dev Disord. 2015 Aug;45(8):2283-94
pubmed: 25737019
JAMA Psychiatry. 2013 Feb;70(2):185-98
pubmed: 23247506
Cortex. 2016 Sep;82:1-10
pubmed: 27268101
World J Biol Psychiatry. 2018 Mar;19(2):101-111
pubmed: 27648848
Curr Psychiatry Rep. 2019 Mar 22;21(5):34
pubmed: 30903299
Neuroimage. 2005 May 1;25(4):1325-35
pubmed: 15850749
J Int Neuropsychol Soc. 2009 May;15(3):331-43
pubmed: 19402919
Neuropsychiatr Dis Treat. 2016 May 12;12:1191-202
pubmed: 27274255
Cereb Cortex. 2016 Aug;26(8):3508-26
pubmed: 27230218
Arch Clin Neuropsychol. 2018 Mar 1;33(2):143-157
pubmed: 29106438
Biol Psychiatry. 2017 Jul 15;82(2):83-102
pubmed: 27887721
Hum Brain Mapp. 2016 Sep;37(9):3323-36
pubmed: 27159198